Effects of transdermal estrogen replacement therapy on cardiovascular risk factors (Q34482114)

2 August 2017

Effects of transdermal estrogen replacement therapy on cardiovascular risk factors (English)

1 reference

2 August 2017

1 reference

1 reference

Dileep V Menon

1

1 reference

PubMed ID

16396517

2 August 2017

Wanpen Vongpatanasin

series ordinal

2

1 reference

2 August 2017

1 January 2006

1 reference

Treatments in Endocrinology: guiding your management of endocrine disorders

2 August 2017

1 reference

2 August 2017

5

1 reference

2 August 2017

1

1 reference

2 August 2017

37-51

1 reference

https://scigraph.springernature.com/pub.10.2165/00024677-200605010-00005

2 August 2017

0 references

cites work

HDL and the inflammatory response induced by LDL-derived oxidized phospholipids

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Soluble P-selectin and the risk of future cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

The effect of different doses of micronized 17beta-estradiol on C-reactive protein, interleukin-6, and lipids in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Transdermal versus oral estrogen therapy in postmenopausal smokers: hemodynamic and endothelial effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Estrogen replacement therapy improves baroreflex regulation of vascular sympathetic outflow in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Body fat and sympathetic nerve activity in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00024677-200605010-00005

10.2165/00024677-200605010-00005

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

16396517

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

16396517